Stock Events

Stock Events

Search...

Ultragenyx Pharmaceutical (0LIF.LSE) Q2 2022 Earnings

5MayConfirmed

Q3 2021

Q4 2021

Q1 2022

Q2 2022

-2.19

-1.82

-1.45

-1.08

Details

Expected EPS

-1.75

Actual EPS

-2.19

Surprise EPS

-0.44

Surprise Percent

+25.14%

Description

Ultragenyx Pharmaceutical (0LIF.LSE) has reported earnings of -2.19 per share for Q2 2022.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.